Allen Chung‐Cheng Huang

机构：Chang Gung Memorial Hospital

发表论文 30 篇 · 总被引 349 次 · h-index 12

代表论文

• Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan (2023 · Targeted Oncology · 被引 27)
• Concomitant infection with COVID-19 and Mycoplasma pneumoniae (2020 · Biomedical Journal · 被引 23)
• Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC (2023 · Scientific Reports · 被引 22)
• First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer (2021 · Therapeutic Advances in Medical Oncology · 被引 21)
• Afatinib treatment in a large real‐world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation (2021 · International Journal of Cancer · 被引 20)
• The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study (2020 · Pharmaceuticals · 被引 18)